Search

everythinglearnresearchcommunity

for

Search:↓

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

ALRN-6924 may prevent hair loss caused by chemotherapy.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Pexidartinib often causes liver issues and fatigue, especially in women.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Suppressing ODC activity reduces tumor growth in hair follicles.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.